Risk of suicidality in depression
with serotonergic antidepressants
by
Matthews JD, Fava M.
Department of Psychiatry,
Massachusetts General Hospital,
Boston 02114, USA.
jmatthews@partners.org
Ann Clin Psychiatry 2000 Mar; 12(1):43-50

ABSTRACT

Since depression is a risk factor for suicidal thoughts and behaviors, and since suicidal behaviors are associated with low serotonin activity, are selective serotonin reuptake inhibitors (SSRIs) more effective than other antidepressants in treating suicidality in depressed patients? There is inconclusive evidence for and against this hypothesis. However, all studies suggest that antidepressants are effective treatments of suicidal ideations and behaviors, and SSRIs have been shown to have prophylactic effects in preventing suicidal behaviors. Although some reports suggest that SSRIs might increase suicidal ideations and behaviors, the results of large, double-blind studies do not suggest a causal relationship between pharmacotherapy and the emergence of suicidality. Undertreatment of depression and therapeutic failure are more significant problems with the use of antidepressants in suicidal patients than the risk of using antidepressants in overdose. Prescribing inadequate doses of antidepressants is therefore a source of overlooked risk.

SSRI suicides?
Essential fatty acids
Glucocorticoids and mood
Suicide: biochemical pathways
How stress triggers depression
Serotonin, the HPA axis and suicide
Suicide rates in the antidepressant era

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family